- Home
- INMD vs IOVA Comparison
INMD vs IOVA Comparison
Compare INMD & IOVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INMD
- IOVA
- Stock Information
- Founded
- INMD 2008
- IOVA 2007
- Country
- INMD Israel
- IOVA United States
- Employees
- INMD N/A
- IOVA N/A
- Industry
- INMD Biotechnology: Electromedical & Electrotherapeutic Apparatus
- IOVA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- INMD Health Care
- IOVA Health Care
- Exchange
- INMD Nasdaq
- IOVA Nasdaq
- Market Cap
- INMD 1.3B
- IOVA 1.2B
- IPO Year
- INMD 2019
- IOVA N/A
- Fundamental
- Price
- INMD $18.61
- IOVA $3.57
- Analyst Decision
- INMD Buy
- IOVA Strong Buy
- Analyst Count
- INMD 5
- IOVA 8
- Target Price
- INMD $22.25
- IOVA $20.25
- AVG Volume (30 Days)
- INMD 1.0M
- IOVA 11.9M
- Earning Date
- INMD 05-01-2025
- IOVA 05-08-2025
- Dividend Yield
- INMD N/A
- IOVA N/A
- EPS Growth
- INMD N/A
- IOVA N/A
- EPS
- INMD 2.25
- IOVA N/A
- Revenue
- INMD $394,818,000.00
- IOVA $164,070,000.00
- Revenue This Year
- INMD $1.92
- IOVA $180.51
- Revenue Next Year
- INMD $5.31
- IOVA $59.81
- P/E Ratio
- INMD $8.11
- IOVA N/A
- Revenue Growth
- INMD N/A
- IOVA 13698.99
- 52 Week Low
- INMD $14.87
- IOVA $3.48
- 52 Week High
- INMD $21.92
- IOVA $15.90
- Technical
- Relative Strength Index (RSI)
- INMD 45.00
- IOVA 29.28
- Support Level
- INMD $17.68
- IOVA $3.55
- Resistance Level
- INMD $18.69
- IOVA $3.84
- Average True Range (ATR)
- INMD 0.73
- IOVA 0.29
- MACD
- INMD -0.15
- IOVA 0.01
- Stochastic Oscillator
- INMD 23.99
- IOVA 12.84
About INMD InMode Ltd.
InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions in the United States. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its product platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF and Morpheus8. The majority of its revenue comes from the United States.
About IOVA Iovance Biotherapeutics Inc.
Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. its objective is to be the leader in innovating, developing, and delivering tumor-infiltrating lymphocyte, or TIL, therapies for patients with solid tumor cancers.